These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26846641)

  • 1. Extracellular Ribonucleic Acids (RNA) Enter the Stage in Cardiovascular Disease.
    Zernecke A; Preissner KT
    Circ Res; 2016 Feb; 118(3):469-79. PubMed ID: 26846641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular nucleic acids in immunity and cardiovascular responses: between alert and disease.
    Preissner KT; Herwald H
    Thromb Haemost; 2017 Jun; 117(7):1272-1282. PubMed ID: 28594050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischaemia/reperfusion injury.
    Cabrera-Fuentes HA; Ruiz-Meana M; Simsekyilmaz S; Kostin S; Inserte J; Saffarzadeh M; Galuska SP; Vijayan V; Barba I; Barreto G; Fischer S; Lochnit G; Ilinskaya ON; Baumgart-Vogt E; Böning A; Lecour S; Hausenloy DJ; Liehn EA; Garcia-Dorado D; Schlüter KD; Preissner KT
    Thromb Haemost; 2014 Dec; 112(6):1110-9. PubMed ID: 25354936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNAs in cardiovascular diseases.
    Uchida S; Dimmeler S
    Circ Res; 2015 Feb; 116(4):737-50. PubMed ID: 25677520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology.
    Thum T; Condorelli G
    Circ Res; 2015 Feb; 116(4):751-62. PubMed ID: 25677521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of extracellular RNA on endothelial barrier function.
    Fischer S; Cabrera-Fuentes HA; Noll T; Preissner KT
    Cell Tissue Res; 2014 Mar; 355(3):635-45. PubMed ID: 24626811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular RNA as a Versatile DAMP and Alarm Signal That Influences Leukocyte Recruitment in Inflammation and Infection.
    Preissner KT; Fischer S; Deindl E
    Front Cell Dev Biol; 2020; 8():619221. PubMed ID: 33392206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RP5-833A20.1/miR-382-5p/NFIA-dependent signal transduction pathway contributes to the regulation of cholesterol homeostasis and inflammatory reaction.
    Hu YW; Zhao JY; Li SF; Huang JL; Qiu YR; Ma X; Wu SG; Chen ZP; Hu YR; Yang JY; Wang YC; Gao JJ; Sha YH; Zheng L; Wang Q
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):87-101. PubMed ID: 25265644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nuclear factor kappaB in cardiovascular health and disease.
    Van der Heiden K; Cuhlmann S; Luong le A; Zakkar M; Evans PC
    Clin Sci (Lond); 2010 Feb; 118(10):593-605. PubMed ID: 20175746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological actions of pentraxins.
    Vilahur G; Badimon L
    Vascul Pharmacol; 2015 Oct; 73():38-44. PubMed ID: 25962566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvesicles as cell-cell messengers in cardiovascular diseases.
    Loyer X; Vion AC; Tedgui A; Boulanger CM
    Circ Res; 2014 Jan; 114(2):345-53. PubMed ID: 24436430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of micro-ribonucleic acid in disease development].
    Widjaya B; Seidelin JB; Olsen J; Nielsen OH
    Ugeskr Laeger; 2009 Nov; 171(47):3441-4. PubMed ID: 19925731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of microRNAs in cardiovascular disease.
    Maegdefessel L
    J Intern Med; 2014 Dec; 276(6):633-44. PubMed ID: 25160930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicle microRNA transfer in cardiovascular disease.
    Das S; Halushka MK
    Cardiovasc Pathol; 2015; 24(4):199-206. PubMed ID: 25958013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Signaling and RNA Regulation in Cardiovascular Diseases.
    Mongelli A; Atlante S; Bachetti T; Martelli F; Farsetti A; Gaetano C
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m6A epitranscriptomic modification of inflammation in cardiovascular disease.
    Zhang YS; Liu ZY; Liu ZY; Lin LC; Chen Q; Zhao JY; Tao H
    Int Immunopharmacol; 2024 Jun; 134():112222. PubMed ID: 38728881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lncing epigenetic control of transcription to cardiovascular development and disease.
    Rizki G; Boyer LA
    Circ Res; 2015 Jul; 117(2):192-206. PubMed ID: 26139858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transduction of reactive oxygen species and mitogen-activated protein kinases in cardiovascular disease.
    Yoshizumi M; Tsuchiya K; Tamaki T
    J Med Invest; 2001 Feb; 48(1-2):11-24. PubMed ID: 11286012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling to translational control pathways: diversity in gene regulation in inflammatory and vascular cells.
    Lindemann SW; Weyrich AS; Zimmerman GA
    Trends Cardiovasc Med; 2005 Jan; 15(1):9-17. PubMed ID: 15795158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA Signature and Cardiovascular Dysfunction.
    Arunachalam G; Upadhyay R; Ding H; Triggle CR
    J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.